Valeant Pharmaceuticals reported CAD13.04B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Amgen AMGN:US $ 140.05B 3.22B
Ani Pharmaceuticals ANIP:US $ 446.53M 345.81K
Aphria Inc APH:CN C$ 2.79B 1.09B
Aurora Cannabis Inc ACB:CN 2.22B 572.15M
Biogen BIIB:US $ 52.13B 9.52B
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Canopy Growth Corp WEED:CN C$ 11.75B 3.46B
Catalent CTLT:US $ 18.42B 490.77M
Corcept Therapeutics CORT:US $ 2.57B 205.11M
Danaher DHR:US $ 191.42B 30.92B
Drreddys Laboratories RDY:US 12.09B 1.86B
Eli Lilly And LLY:US $ 220.12B 40.96B
Endo International Ordinary Shares ENDP:US 1.09B 616.14M
Gilead Sciences GILD:US $ 86.36B 4.99B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Horizon Pharma HZNP:US 21.05B 423.52M
Lannett LCI:US $ 193.55M 25.05M
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Pacira Pharmaceuticals PCRX:US $ 2.67B 402.93M
Perrigo Ordinary Shares PRGO:US 6.12B 717.76M
Phibro Animal Health PAHC:US $ 1.17B 182.68M
Prestige Brands PBH:US $ 2.61B 410.09M
Revance Therapeutics RVNC:US $ 2.13B 132.96M
Supernus Pharmaceuticals SUPN:US $ 1.64B 250.8M
Valeant Pharmaceuticals VRX:CN C$ 13.04B 1.14B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
Zoetis ZTS:US $ 88.48B 13.67B